Proxima
@proximabio
Followers
3K
Following
197
Media
74
Statuses
196
Decode and design the interfaces of life
New York, NY
Joined September 2020
Excited to announce that our team at Proxima (formerly VantAI) has raised $80M in new funding led by @DCVC, with @nvidia, Braidwell, @Roivant, @aixventureshq, Yosemite, Magnetic Ventures, Alexandria Venture Investments, @ModiVentures, and others. We are building the platform
5
22
56
Big congrats @mmbronstein! “Seed” 😅 👏👏👏👏👏 🫡🇺🇸
Big news from @proximabio (formerly known as VantAI), a pioneer of AI-driven drug discovery for proximity therapeutics
2
2
10
Interactomics is biology’s next data frontier. To truly solve disease, we need to understand the dynamic interfaces proteins form, and learn how to edit them systematically. Enter Proxima! Thrilled to have DCVC, NVIDIA, and an incredible syndicate of partners joining us on this
Excited to announce that our team at Proxima (formerly VantAI) has raised $80M in new funding led by @DCVC, with @nvidia, Braidwell, @Roivant, @aixventureshq, Yosemite, Magnetic Ventures, Alexandria Venture Investments, @ModiVentures, and others. We are building the platform
1
4
22
Incredibly excited to introduce Proxima, our next chapter. Frontier models and a phase-shifting data engine, backed by an amazing group of investors, to unlock one of the most exciting new classes of medicines - Proximity Modulators.
Excited to announce that our team at Proxima (formerly VantAI) has raised $80M in new funding led by @DCVC, with @nvidia, Braidwell, @Roivant, @aixventureshq, Yosemite, Magnetic Ventures, Alexandria Venture Investments, @ModiVentures, and others. We are building the platform
8
5
61
.@proximabio = progress: that's why @DCVC led the $80M seed we announced yesterday. Signed collaborations with J&J, Bristol Myers Squibb, and Blueprint Medicines (now in Sanofi) could bring in billions of dollars in upfront and milestone payments and royalties.
0
2
7
📢 The VantAI team is thrilled to be at NeurIPS 2025! 💥 If you’re interested in meeting with a member of our team for a coffee chat, drop your details at this link and we’ll follow up to schedule https://t.co/N9Aah7Qwmr
0
3
12
We're thrilled to partner with @HaldaTx to expand the reach of their groundbreaking RIPTAC platform. Together, we're working to identify new therapeutic target-effector combinations that will help enable this innovative proximity-based approach to unlock new treatment
0
9
19
Neo just got much faster!💥 Working closely with @NVIDIAHealth, VantAI adopted #cuEquivariance, leading to massive speedups. Today's announcement is a big advancement for the field!
Did you know the NVIDIA #cuEquivariance library can now accelerate Triangle Attention and Triangle Multiplication operations? Say goodbye to AI model bottlenecks — get up to 2x speedups in training and inference to build and train bigger models. We’re excited that the next-gen
1
6
23
Excited to announce our second expansion in three years with @BlueprintMeds. Together, we will prioritize novel target-effector pairs for molecular glue development, aiming at previously undruggable targets, using our proximity modulator discovery platform powered by our Neo-1
0
2
12
last night's @airstreet nyc ai meetup hosted at @awscloud showcased sota coding agents, workflow agents, generative user interfaces and protein and molecular design tools. some seriously impressive demos from: - @ashedwardst of @Fern_Labs with long-running computer agents -
5
5
19
We are excited to announce the first alpha release of 💥 peppr - package for evaluation of predicted poses 💥 an open source framework for structural model evaluation Find out more at https://t.co/RCUVhx0wHg built on @biotite_python, peppr dramatically simplifies evaluation
16
22
105
Drug discovery turned out to be too hard, so VantAI has made the important decision to pivot from molecular glues to regular glues, and today we are thrilled to announce a landmark $800B biobucks deal with Elmer’s. CTO Luca Naef (@NaefLuca) explains, “When we first prompted
5
4
89
Excited to finally share what we’ve been working on for the past year: Neo-1, a unified model for all-atom structure prediction and generation of both proteins and other molecules! 🧬🔬
Announcing Neo-1: the world’s most advanced atomistic foundation model, unifying structure prediction and all-atom de novo generation for the first time - to decode and design the structure of life 🧵(1/10)
5
7
89
Really cool to see Neo-1 released. Latent diffusion to combine structure prediction and molecular generation across modalities. #ai #drugdiscovery #genai
Announcing Neo-1: the world’s most advanced atomistic foundation model, unifying structure prediction and all-atom de novo generation for the first time - to decode and design the structure of life 🧵(1/10)
2
2
25
Big news from @vant_ai: Neo-1 integrates SOTA structure prediction and all-atom molecular generation into a single unified model -- an industry first to the best of my knowledge: https://t.co/Z9kthghP5h
3
15
106